Choosing therapy for childhood asthma

Pediatric Drugs

Volumn 3, Issue 12, 2001, Pages 915-925

  Lemanske Jr , Robert F ^a  

^a University of Wisconsin Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL; THEOPHYLLINE DERIVATIVE;

ASTHMA; BRONCHUS REACTIVITY; DRUG EFFICACY; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0035692438     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200103120-00004     Document Type: Review

References (52)

1. Evidence-based health policy: Lessons from the Global Burden of Disease Study
2. Establishing a therapeutic index for the inhaled corticosteroids (part I): Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids
3. Efficacy and safety overview of a new inhaled corticosteroid. QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma
4. Long-term effects of budesonide or nedocromil in children with asthma
5. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
6. A comparison of beclomethasone, salmeterol, and placebo in children with asthma
7. Nonbronchodilator effects of inhaled beta 2 agonists: Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma
8. Salmeterol in paediatric asthma
9. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma
10. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature
11. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study)
12. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma
13. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT)
14. Comparison of the effects of intravenous and oral montelukast on airway function: A double blind, placebo controlled, three period, crossover study in asthmatic patients
15. Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double blind trial
16. Montelukast, a leukotriene receptor antagonist for the treatment of persistent asthma in children aged 2 to 5 years
17. Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover study
18. The changing role of theophylline in pediatric asthma
19. Slow-release theophylline for the treatment of asthmatic children
20. Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma
21. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma
22. Once-daily theophylline reduces serum eosinophil cationic protein and eosinophil levels in induced sputum of asthmatics
23. Oral versus intravenous corticosteroids in children hospitalized with asthma
24. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma
25. High-dose systemic glucocorticoid therapy in the treatment of severe asthma: A case of resistance and patterns of response
26. Acute asthma: Single dose oral steroids in paediatric community clinics
27. Single dose oral steroids in paediatric community clinics
28. Clinical outcomes of steroid-insensitive asthma
29. A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucoase and asthma symptoms in patients with atopic asthma
30. Do inhaled corticosteroids inhibit growth in children?
31. A meta-analysis of the effect of oral and inhaled corticosteroids on growth
32. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma
33. Effects of inhaled corticosteroid on bone turnover in children with bronchial asthma
34. Systemic adverse effects of inhaled corticosteroid therapy: A system review and meta-analysis
35. Use of inhaled corticosteroids and the risk of cataracts
36. The risk of cataract among users of inhaled steroids
37. Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide
38. Oral prednisone as a risk factor for infections in children with asthma
39. Growth suppression by glucocorticoid therapy
40. Perspectives in beta-2-agonist therapy: Vox clamantis in deserto vel lux in tenebris
41. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma
42. Theophylline in asthma
43. Asthma drug adherence in a long term clinical trial
44. Inhalation therapy in asthma: Nebulizer or pressurized metered-dose inhaler with holding chamber: In vivo comparison of lung deposition in children?
45. Drug delivery from the turbuhaler and nebuhaler pressurized metered dose inhaler to various age groups of children with asthma
46. Poor inhalation technique, even after inhalation instructions, in children with asthma
47. Inhalation therapy in asthma: Nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children
48. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
49. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group
50. Treatment of childhood asthma with anti-IgE antibody (omalizumab)